Product Information
RUFINAMIDE 200 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.8636 per EA under NDC 68180080316. Its NADAC has been published 167 times since Mar 22, 2023.
Strength
200 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180080316
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RUFINAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204964On Market Since
11/28/2022
Price Statistics
The NADAC for RUFINAMIDE 200 MG TABLET has been published 167 times since Mar 22, 2023, and over the history we have for it it has declined 64.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8636 per EA |
|---|---|
| All-time high | $2.3971 (Sep 13, 2023) |
| All-time low | $0.8636 (Jun 17, 2026) |
| 52-week high | $1.5412 |
| 52-week low | $0.8636 |
| Median price | $1.5186 |
| Average price | $1.6366 |
| Largest weekly change | -14.2% (Nov 19, 2025) |
| Weeks tracked | 167 |
| Tracking since | Mar 22, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RUFINAMIDE 200 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RUFINAMIDE 200 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.8636 per EA (NDC 68180080316), effective Jun 24, 2026.
How has the price of RUFINAMIDE 200 MG TABLET changed over time?
Over the history we have for it, the NADAC for RUFINAMIDE 200 MG TABLET has declined 64.0%. It has been tracked across 167 weekly CMS publications since Mar 22, 2023.
What are the highest and lowest recorded NADAC prices for RUFINAMIDE 200 MG TABLET?
Since Mar 22, 2023, the NADAC for RUFINAMIDE 200 MG TABLET has ranged from a low of $0.8636 (Jun 17, 2026) to a high of $2.3971 (Sep 13, 2023), with a median of $1.5186 per EA.
Are there cheaper alternatives to RUFINAMIDE 200 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as RUFINAMIDE 200 MG TABLET, but none are currently priced below it.
Who manufactures RUFINAMIDE 200 MG TABLET?
RUFINAMIDE 200 MG TABLET (NDC 68180080316) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification